Inventurus Knowledge Solutions (IKS) Shares Investor FAQs on Additional Investment in WWMG MSO

Key Metrics:

What Happened ?

Key Details

Key Takeaways from the Investor FAQ:

• IKS has approved an equity infusion of US$15 million through March 2029, with an immediate investment of US$3 million scheduled by July 3, 2026.
• Capital will primarily support:
  • Physician hiring
  • Expansion of Value-Based Care (VBC)
  • General working capital
  • Growth initiatives across the physician platform
• The physician network continues to expand:
  • 13 recently acquired physicians are currently ramping up.
  • Recruitment of 9 additional physicians is planned within the next six months.
• Platform implementation is largely complete after resolving initial Epic access issues.
• Approximately 95% of clinicians have successfully migrated to the Scribble platform.
• Multiple digital healthcare tools are operational, including:
  • Virtual Clinic Assistant
  • Referral Management
  • My Care Hub
• Remaining work is focused on resolving data compatibility for Prior Authorization workflows.
• Total investment in WWMG currently stands at US$17 million and is expected to increase to approximately US$32 million by 2029.
• Operational improvements include:
  • Reduction in Days Sales Outstanding from 46.1 days to 41.7 days
  • Annualised cost savings of approximately US$2.5 million
  • 3% month-on-month increase in patient visit volumes during April–May 2026
• Existing Value-Based Care agreements have been renegotiated to improve future revenue generation.
• WWMG continues to serve as:
  • A strategic reference customer
  • A brand ambassador for IKS
  • A validation platform for physician-led healthcare solutions
  • A key enabler in obtaining an Accountable Care Organization (ACO) Convener licence

Note:

• The FAQ primarily provides operational and strategic updates and does not disclose quarterly financial performance such as revenue, EBITDA, PAT, margins, or segment-wise earnings.

Risk Analysis

Summary:

• While execution is progressing as planned, successful realization of investment returns depends on continued physician onboarding, platform integration, operational scaling, and revenue growth from Value-Based Care initiatives.

Key Risks:

• Remaining platform integration work for Prior Authorization workflows.
• Physician recruitment and productivity ramp-up timelines.
• Dependence on successful commercialization of expanded healthcare services.
• Long-term return on investment depends on execution of expansion strategy.

Worst Case:

• Delays in physician onboarding, platform implementation, or slower-than-expected revenue realization could postpone anticipated operational leverage and investment returns.

Risk Level: Medium

Company Commentary

• Investment proceeds will support physician expansion, Value-Based Care initiatives and working capital.
• Platform implementation has substantially progressed with 95% clinician adoption.
• Operational efficiencies are improving through Revenue Cycle Management optimisation.
• Annualised cost savings of approximately US$2.5 million are expected.
• Visit volumes are increasing as platform deployment accelerates.
• Existing VBC agreements have been renegotiated to support future revenue growth.
• WWMG continues to play a strategic role as a reference customer and partner for future business development.
• Management expects the investment to generate returns in line with the company’s long-term business objectives.